NCT03326323View on ClinicalTrials.gov

Biomarker and Thrombogenicity Assessment in Cardiopulmonary Bypass Surgery Utilizing Acute Normovolemic Hemodilution

CompletedOBSERVATIONAL
Enrollment

43

Participants

Timeline

Start Date

March 19, 2018

Primary Completion Date

September 17, 2019

Study Completion Date

October 17, 2019

Conditions
Bleeding Reduction
Interventions
PROCEDURE

Acute Normovolemic Hemodilution

Collection and reinfusion of a patients own blood during coronary artery bypass graft surgery.

Trial Locations (1)

22042

Inova Heart and Vascular Institute, Falls Church

Sponsors
All Listed Sponsors
collaborator

Instrumentation Laboratory

INDUSTRY

lead

Inova Health Care Services

OTHER